| Dr Alan D Brook, MD | |
|
6 Jungermann Cir, Suite 210, Saint Peters, MO 63376-1621 | |
| (636) 441-6056 | |
| (636) 441-0620 |
| Full Name | Dr Alan D Brook |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 40 Years |
| Location | 6 Jungermann Cir, Saint Peters, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316938863 | NPI | - | NPPES |
| 204014518 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 103141 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Barnes-jewish St Peters Hospital | Saint peters, MO | Hospital |
| Progress West Hospital | O fallon, MO | Hospital |
| Christian Hospital Northeast | Saint louis, MO | Hospital |
| Barnes Jewish Hospital | Saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary Consultants,inc | 1355317280 | 12 |
News Archive
Today the Indoor Tanning Association (ITA) denounced Introduced Resolution 1714, which would ban Suffolk teens under the age of 18 from using a sun-bed.
"A drought in the Horn of Africa, triggered by the same La Nina episode that caused massive flooding in Australia last year, is plunging millions of pastoralists closer to food insecurity," Greenwire/New York Times reports in a story looking at how the drought is affecting several areas in the region.
Florida-based biopharmaceutical company Oragenics, Inc. announced that it will receive a $733,437 Federal Grant as part of Congress's Patient Protection and Affordable Care Act of 2010.
Retinoblastoma is a cancer that forms in the light-detecting cells in the back of the eye. It often appears in children under two years of age and can lead to blindness or eye removal. Most cancers are biopsied and studied so that medical research can design targeted treatments. Unfortunately, this is not possible with retinoblastoma.
AbbVie, a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its investigational selective JAK1 inhibitor, ABT-494, in patients with inadequate response to either methotrexate or TNF inhibitors.
› Verified 5 days ago
| Entity Name | Ste Genevieve County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801817416 PECOS PAC ID: 3274432802 Enrollment ID: O20040617000089 |
News Archive
Today the Indoor Tanning Association (ITA) denounced Introduced Resolution 1714, which would ban Suffolk teens under the age of 18 from using a sun-bed.
"A drought in the Horn of Africa, triggered by the same La Nina episode that caused massive flooding in Australia last year, is plunging millions of pastoralists closer to food insecurity," Greenwire/New York Times reports in a story looking at how the drought is affecting several areas in the region.
Florida-based biopharmaceutical company Oragenics, Inc. announced that it will receive a $733,437 Federal Grant as part of Congress's Patient Protection and Affordable Care Act of 2010.
Retinoblastoma is a cancer that forms in the light-detecting cells in the back of the eye. It often appears in children under two years of age and can lead to blindness or eye removal. Most cancers are biopsied and studied so that medical research can design targeted treatments. Unfortunately, this is not possible with retinoblastoma.
AbbVie, a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its investigational selective JAK1 inhibitor, ABT-494, in patients with inadequate response to either methotrexate or TNF inhibitors.
› Verified 5 days ago
| Entity Name | Pulmonary Consultants,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164534210 PECOS PAC ID: 1355317280 Enrollment ID: O20081210000646 |
News Archive
Today the Indoor Tanning Association (ITA) denounced Introduced Resolution 1714, which would ban Suffolk teens under the age of 18 from using a sun-bed.
"A drought in the Horn of Africa, triggered by the same La Nina episode that caused massive flooding in Australia last year, is plunging millions of pastoralists closer to food insecurity," Greenwire/New York Times reports in a story looking at how the drought is affecting several areas in the region.
Florida-based biopharmaceutical company Oragenics, Inc. announced that it will receive a $733,437 Federal Grant as part of Congress's Patient Protection and Affordable Care Act of 2010.
Retinoblastoma is a cancer that forms in the light-detecting cells in the back of the eye. It often appears in children under two years of age and can lead to blindness or eye removal. Most cancers are biopsied and studied so that medical research can design targeted treatments. Unfortunately, this is not possible with retinoblastoma.
AbbVie, a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its investigational selective JAK1 inhibitor, ABT-494, in patients with inadequate response to either methotrexate or TNF inhibitors.
› Verified 5 days ago
| Entity Name | Mercy Hospital Perry |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063117158 PECOS PAC ID: 1153777826 Enrollment ID: O20231101001515 |
News Archive
Today the Indoor Tanning Association (ITA) denounced Introduced Resolution 1714, which would ban Suffolk teens under the age of 18 from using a sun-bed.
"A drought in the Horn of Africa, triggered by the same La Nina episode that caused massive flooding in Australia last year, is plunging millions of pastoralists closer to food insecurity," Greenwire/New York Times reports in a story looking at how the drought is affecting several areas in the region.
Florida-based biopharmaceutical company Oragenics, Inc. announced that it will receive a $733,437 Federal Grant as part of Congress's Patient Protection and Affordable Care Act of 2010.
Retinoblastoma is a cancer that forms in the light-detecting cells in the back of the eye. It often appears in children under two years of age and can lead to blindness or eye removal. Most cancers are biopsied and studied so that medical research can design targeted treatments. Unfortunately, this is not possible with retinoblastoma.
AbbVie, a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its investigational selective JAK1 inhibitor, ABT-494, in patients with inadequate response to either methotrexate or TNF inhibitors.
› Verified 5 days ago
| Entity Name | Mercy Hospital Perry |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1063117158 PECOS PAC ID: 1153777826 Enrollment ID: O20231106001433 |
News Archive
Today the Indoor Tanning Association (ITA) denounced Introduced Resolution 1714, which would ban Suffolk teens under the age of 18 from using a sun-bed.
"A drought in the Horn of Africa, triggered by the same La Nina episode that caused massive flooding in Australia last year, is plunging millions of pastoralists closer to food insecurity," Greenwire/New York Times reports in a story looking at how the drought is affecting several areas in the region.
Florida-based biopharmaceutical company Oragenics, Inc. announced that it will receive a $733,437 Federal Grant as part of Congress's Patient Protection and Affordable Care Act of 2010.
Retinoblastoma is a cancer that forms in the light-detecting cells in the back of the eye. It often appears in children under two years of age and can lead to blindness or eye removal. Most cancers are biopsied and studied so that medical research can design targeted treatments. Unfortunately, this is not possible with retinoblastoma.
AbbVie, a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its investigational selective JAK1 inhibitor, ABT-494, in patients with inadequate response to either methotrexate or TNF inhibitors.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan D Brook, MD 11133 Dunn Rd, Suite 2335, Saint Louis, MO 63136-6119 Ph: (314) 653-5007 | Dr Alan D Brook, MD 6 Jungermann Cir, Suite 210, Saint Peters, MO 63376-1621 Ph: (636) 441-6056 |
News Archive
Today the Indoor Tanning Association (ITA) denounced Introduced Resolution 1714, which would ban Suffolk teens under the age of 18 from using a sun-bed.
"A drought in the Horn of Africa, triggered by the same La Nina episode that caused massive flooding in Australia last year, is plunging millions of pastoralists closer to food insecurity," Greenwire/New York Times reports in a story looking at how the drought is affecting several areas in the region.
Florida-based biopharmaceutical company Oragenics, Inc. announced that it will receive a $733,437 Federal Grant as part of Congress's Patient Protection and Affordable Care Act of 2010.
Retinoblastoma is a cancer that forms in the light-detecting cells in the back of the eye. It often appears in children under two years of age and can lead to blindness or eye removal. Most cancers are biopsied and studied so that medical research can design targeted treatments. Unfortunately, this is not possible with retinoblastoma.
AbbVie, a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its investigational selective JAK1 inhibitor, ABT-494, in patients with inadequate response to either methotrexate or TNF inhibitors.
› Verified 5 days ago
Furqan F Raja, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 70 Jungermann Circle, Suite 405, Saint Peters, MO 63376 Phone: 636-720-0310 Fax: 636-720-0311 | |
Dr. Pierre Moeser, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 70 Jungermann Cir, Ste 300, Saint Peters, MO 63376 Phone: 636-916-9020 Fax: 636-916-9021 | |
Dr. Ron Javdan, M.D. Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 6 Jungermann Cir, Suite 203, Saint Peters, MO 63376 Phone: 636-928-1822 Fax: 636-441-7033 | |
Dr. Lawrence Osei, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Dept Anesthesiology, Saint Peters, MO 63376 Phone: 800-862-9980 Fax: 314-362-1185 | |
Dr. Anna Roshal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 150 Entrance Way, Saint Peters, MO 63376 Phone: 636-916-9920 Fax: 636-916-9176 | |
Dr. Sandeep Hindupur, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr Ste 100, Saint Peters, MO 63376 Phone: 636-916-7272 | |
April Thebeau, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 314-317-0600 Fax: 314-317-0606 |